Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
219
-
Total 13F shares, excl. options
-
58.8M
-
Shares change
-
+4.68M
-
Total reported value, excl. options
-
$4.02B
-
Value change
-
+$309M
-
Put/Call ratio
-
1.57
-
Number of buys
-
111
-
Number of sells
-
-129
-
Price
-
$68.35
Significant Holders of Biohaven Pharmactl Hldg Co L - COM (BHVN) as of Q1 2021
302 filings reported holding BHVN - Biohaven Pharmactl Hldg Co L - COM as of Q1 2021.
Biohaven Pharmactl Hldg Co L - COM (BHVN) has 219 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.8M shares
.
Largest 10 shareholders include Capital International Investors (5.58M shares), Capital World Investors (4.74M shares), BlackRock Inc. (3.78M shares), MARSHALL WACE, LLP (2.78M shares), STIFEL FINANCIAL CORP (2.56M shares), ORACLE INVESTMENT MANAGEMENT INC (2.12M shares), RP Management, LLC (2.11M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.02M shares), WELLINGTON MANAGEMENT GROUP LLP (1.82M shares), and JPMORGAN CHASE & CO (1.75M shares).
This table shows the top 219 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.